【発明の名称】タイプ33α-ヒドロキシステロイドデヒドロゲナーゼの阻害

Title:

【発明の名称】タイプ33α-ヒドロキシステロイドデヒドロゲナーゼの阻害

Document Type and Number:

Japanese Patent JP2002522380

Kind Code:

A

Abstract:

Novel methods of treating and/or inhibiting development of prostatic cancer, benign prostatic hyperplasia, prostatitis, acne, seborrhea, hirsutism or androgenic alopecia utilize inhibitors of type 3 3 alpha -hydroxysteroid dehydrogenase alone or in combination with other active pharmaceuticals such as inhibitors of type 5 17 beta -hydroxysteroid dehydrogenase. Novel inhibitors and pharmaceutical products are also disclosed.

More Like This:

WO/1998/051706	TUMOR-ASSOCIATED ANTIGEN
WO/2005/095613	Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF
JP2006503048	Phenyl-aza-benzimidazole compounds for regulating IgE and inhibiting cell growth

Inventors:

Fernando Lovely
Eve Mellan
Sylvain Gautier
Louis Provencher
Ban Lo-Te

Application Number:

JP2000563261A

Publication Date:

July 23, 2002

Filing Date:

August 06, 1999

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ENDORECHERCHE, INC.

International Classes:

A61K45/00; A61K31/566; A61K31/567; A61K31/5685; A61K31/585; A61K45/06; A61P35/00; A61P43/00; C07J1/00; C07J21/00; (IPC1-7): A61K45/00; A61K31/567; A61P35/00; A61P43/00

Attorney, Agent or Firm:

Aoyama Ryo (2 outside people)

Previous Patent: ミクロエマルションを形成可能な、活性物質の持続放出を有する組成物

Next Patent: 粘膜保護用医薬としてのホスファチジルコリン